Vittia S.A.

Vittia S.A.

3.55
BRL
-0.12
(-3.27%)
0.41EPS
8.00P/E
511.22MMarket Cap
Nov 11Next Earn
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.21
1.81
4.84
4.39
4.77
4.99
5.12
Basic EPS, GAAP
0.49
0.36
0.85
0.57
0.46
0.41
0.41
Free Cash Flow per Basic Share
-0.08
-0.17
0.33
0.56
0.2
0.47
0.79
Dividend per Share
0.19
0.14
0.11
0.18
0.23
0.21
0.23
Book Value per Share
1.73
2.78
3.35
3.6
3.85
3.99
3.85
Tangible Book Value per Share
1.6
2.66
3.24
3.5
3.75
3.91
3.77
Basic Weighted Avg Shares
165
156
176
172
165
164
160
Sales/Revenue/Turnover
531
284
851
756
787
820
819
Operating Margin (%)
19.51
28.62
21.11
12.79
11.26
8.96
8.39
Depreciation Expense
8
11
16
20
22
25
25
Net Income, GAAP
82
56
150
97
76
67
65
Effective Tax Rate (%)
7.63
28.47
13.49
- -
19
9.14
7.98
Profit Margin (%)
15.41
19.65
17.62
12.88
9.6
8.11
7.96
Working Capital
170
294
355
294
369
359
292
LT Debt
66
51
85
27
96
68
64
Total Equity
291
486
580
620
635
644
604
Return on Invested Capital (%)
- -
9.07
19.6
- -
8.4
7.63
7.49
Return on Capital (%)
- -
10.2
27.02
- -
10.76
10.51
11.61
Return on Common Equity (%)
- -
14.54
28.36
16.25
12.03
10.4
10.82

Capital Structure

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
132
183
162
LT Borrowings
49
48
47
LT Finance Leases
19
18
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
161
160
157
Market Capitalization
675
631
511

Working Capital

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
576
601
542
Cash, Cash Equivalents & STI
48
50
106
Accounts Receivable, Net
328
345
186
Inventories
157
170
210
Total Current Liabilities
217
265
250
Payables & Accruals
- -
- -
- -
ST Debt
132
183
162
Deferred Revenue
- -
- -
- -

Growth Rates

BRL

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
19.42%
1.49%
Free Cash Flow
- -
-19.05%
138.37%
Net Income, GAAP
- -
13.57%
-11.91%
Sales/Revenue/Turnover
- -
30.12%
4.24%
Total Cash Common Dividend
- -
6.09%
-11.53%

Quarterly Revenue

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
122
100
309
255
787
2025
138
99
325
258
820
2026
122
114
- -
- -
- -

Quarterly Earnings Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.11
0.28
0.28
0.46
2025
-0.01
-0.13
0.24
0.31
0.41
2026
-0.04
-0.11
- -
- -
- -

Quarterly Dividends Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.13
0.09
- -
- -
0.23
2025
0.12
0.01
0.07
- -
0.21
2026
0.07
0.09
- -
- -
- -

Company Description

CEO
Wilson Fernando Romanini
Full Time Employees
1,110
Sector
Process industries
Industry
Chemicals: agricultural
Address
Sao Joaquim da Barra Brazil
IPO Date
Sep 2, 2021
Business
Vittia S.A. is a Brazilian agribusiness company that develops, produces, and commercializes special fertilizers, biological crop protection solutions, inoculants, and plant nutrition technologies for the agricultural sector. Founded in 1971 and headquartered in São Joaquim da Barra, State of São Paulo, Brazil, the company operates primarily across major agricultural regions in Brazil, serving farmers, agricultural cooperatives, and input distributors involved in the cultivation of soybeans, corn, sugarcane, coffee, cotton, citrus, cereals, and horticultural crops. Vittia conducts its operations through specialized units and brand portfolios including Biosoja, Samaritá, Biovalens, and Granorte, maintaining industrial and research facilities across the states of São Paulo and Minas Gerais. The company organizes its product and service offerings into five core segments: Special Foliar and Soil Fertilizers, comprising liquid and soluble foliar fertilizers, chelated micronutrients, secondary macronutrients, controlled-release fertilizers, and fertigation formulas designed to enhance plant physiology and crop productivity; Biological Crop Protection (Biodefensives), comprising microbiological fungicides, bio-insecticides, and bio-nematicides derived from beneficial bacterial and fungal strains such as Bacillus, Trichoderma, and Beauveria for sustainable pest and disease management; Inoculants and Bio-stimulants, comprising microbiological seed treatments and bacterial inoculants, including Bradyrhizobium and Azospirillum strains, that facilitate biological nitrogen fixation and root development; Organomineral and Soil Conditioners, comprising granulated organomineral fertilizers, humic and fulvic substances, and soil fertility restorers; and Agricultural Adjuvants, comprising spray drift retardants, penetrants, spreading agents, and water conditioners that optimize agrochemical application efficiency. Core proprietary product lines include Biomaphos, a biological phosphorus solubilizer; No-Nemat, a biological nematicide; and tailored crop nutrition solutions under the Biosoja and Samaritá brands. In recent strategic developments, Vittia S.A. has accelerated its expansion in the biologicals and bio-inputs market by expanding high-capacity fermentation and formulation facilities to scale up production of microbiological pest control agents and biological inoculants. The company has consolidated the integration of strategic acquisitions, including Biovalens and Agro Latina, enhancing its biotechnology research and manufacturing capabilities. Vittia has introduced new biological product registrations to its portfolio, notably multi-strain bionematicides and biofungicides, while expanding its distribution footprint through strategic commercial partnerships with leading agricultural retail networks and regional cooperatives across the Brazilian Cerrado, Midwest, and Southern agricultural belts. Furthermore, the company continues to advance operational initiatives focused on soil microbiome health, biological nutrient solubilization, and decarbonization-focused agricultural practices.